By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Acquisition and development of small molecule therapeutics for the treatment of serious diseases123.32K100.00%
By Country/Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States1M100.00%